Detection no Invasive of a Silent Myocardial Ischemia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

47 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-04-15

Study Completion Date

2018-04-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The pathophysiological features of myocardial diabetic subject combined with cardiac autonomic neuropathy were behind the quietness of myocardial ischemia, known as silent myocardial ischemia (IMS). These patients have the risk to remain asymptomatic until the sudden onset of a myocardial infarction, or even sudden death.

That is why the investigators want to evaluate the contribution of non-invasive tools to stand in the diagnosis of IMS patients with diabetes type 2, asymptomatic heart on map: Technical myocardial speckle tracking in studying strains overall average left ventricular (longitudinal, circumferential and radial) measured in 2D and 3D at rest, compared to stress echocardiography with dobutamine (ESD)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Peripheral Endothelial Function and Coronary Status in Asymptomatic Diabetic Patients

NCT00685984

Myocardial Ischemia

COMPLETED

Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients

NCT00202670

Diabetes Mellitus

TERMINATED

Diabetic Cardiomyopathy

NCT04593173

Diabetic Cardiomyopathies

UNKNOWN

Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes

NCT02505451

Diabetes-related Complications

COMPLETED NA

Alteration of Myocardial Deformations in Diabetes: Relationship to Micro-angiopathy

NCT01220349

Diabetes Mellitus, Type 1

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Silent Myocardial Ischemia Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

echography

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* With at least two cardiovascular risk factors including: hypertension, dyslipidemia, smoking active or interrupted for less than 3 years, family history (relatives of the 1st degree) Accident major CV before 60.
* Or whatever the level of risk factors: peripheral artery disease and / or carotid atherosclerosis, or proteinuria

Exclusion Criteria

* Valvular heart disease (severe to moderate valvular ) , hypertrophic , dilated , chronic lung
* History of cardiotoxic chemotherapy
* Atrioventricular blocks of degree
* Asthma
* Recent stroke within a month
* Bilateral carotid stenosis tight
* Glaucoma untreated narrow angle
* Subject to exclusion period (determined by a previous study or in progress)
* Inability to give informed about information
* patient under judicial protection
* patient guardianship or curatorship
* Current pregnancy (women of childbearing age )
* Breastfeeding

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No